Administration of Autologous Mesenchymal Stem Cell Transplantation for Treatment of Type 1 Diabetes Mellitus

Administration of Autologous Mesenchymal Stem Cell Transplantation for Treatment of Type 1 Diabetes Mellitus

Background: The aim of the present clinical trial was to investigate the efficacy of autologous bone marrow mesenchymal stem cells (BM-MSCs) in glycemic control of diabetic patients without using any immunosuppressive drugs over a nine-month period. Method: Twenty-three patients with T1DM, at 5...

Full description

Bibliographic Details
Main Authors: Ensieh NASLI ESFAHANI, Ardeshir GHAVAMZADEH, Nika MOJAHEDYAZDI, SeyyedJafar HASHEMIAN, Kamran ALIMOGHADAM, Nar­jes AGHEL, Behrouz NIKBIN, Bagher LARIJANI
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2015-10-01
Series:Iranian Journal of Public Health
Online Access:https://ijph.tums.ac.ir/index.php/ijph/article/view/4916

Internet

https://ijph.tums.ac.ir/index.php/ijph/article/view/4916

Similar Items